VanEck Associates
DXCM icon

VanEck Associates’s DexCom DXCM Stock Holding History

VanEck Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.28M Buy
137,854
+2,479
+2% +$165K 0.01% 650
2026
Q1 		$8.5M Buy
135,375
+11,021
+9% +$767K 0.01% 635
2025
Q4 		$8.25M Buy
124,354
+47,226
+61% +$3.05M 0.01% 625
2025
Q3 		$5.19M Sell
77,128
-5,946
-7% -$471K ﹤0.01% 755
2025
Q2 		$7.25M Sell
83,074
-2,991
-3% -$234K 0.01% 589
2025
Q1 		$5.88M Buy
86,065
+252
+0.3% +$20.6K 0.01% 650
2024
Q4 		$6.67M Buy
85,813
+65,622
+325% +$4.86M 0.01% 588
2024
Q3 		$1.46M Buy
20,191
+2,475
+14% +$203K ﹤0.01% 951
2024
Q2 		$2.01M Buy
17,716
+1,274
+8% +$161K ﹤0.01% 882
2024
Q1 		$2.28M Sell
16,442
-1,517
-8% -$191K ﹤0.01% 825
2023
Q4 		$2.23M Sell
17,959
-2,674
-13% -$273K ﹤0.01% 776
2023
Q3 		$1.93M Buy
20,633
+1,877
+10% +$212K ﹤0.01% 754
2023
Q2 		$2.41M Sell
18,756
-1,199
-6% -$145K 0.01% 680
2023
Q1 		$2.32M Buy
19,955
+9,326
+88% +$1.04M 0.01% 675
2022
Q4 		$1.2M Buy
10,629
+4,385
+70% +$481K ﹤0.01% 769
2022
Q3 		$503K Buy
+6,244
New +$529K ﹤0.01% 889
2022
Q1 		– Sell
-1,232
Closed -$165K – 1380
2021
Q4 		$165K Buy
+1,232
New +$177K ﹤0.01% 1144
2021
Q1 		– Sell
-5,284
Closed -$488K – 1229
2020
Q4 		$488K Buy
5,284
+3,524
+200% +$315K ﹤0.01% 778
2020
Q3 		$181K Buy
+1,760
New +$184K ﹤0.01% 829

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

VanEck Associates's DXCM Position: Q2 2026 in Review

VanEck Associates increased its DexCom (DXCM) stake by 1.8% in Q2 2026, buying an estimated $165K and bringing the position to 137,854 shares worth $9.28M. The position accounts for 0.01% of the portfolio, ranked #650.

VanEck Associates first reported a position in DXCM in Q3 2020 and has held it in 19 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • VanEck Associates held 137,854 shares of DexCom worth $9.28M as of Q2 2026.
  • VanEck Associates bought 2,479 DexCom shares in Q2 2026, an estimated $165K.
  • DexCom made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #650 holding.
  • VanEck Associates first reported a position in DexCom in Q3 2020 and has held it in 19 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.